Best Genomics Companies in Sweden
The 63 best Genomics companies in Sweden in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Immunovia.
- Genomics Market Surges with PCR and AI Technologies Projected to Reach
- Genomics Market Size to Grow by USD 18,244.34 million from 2022 to 202
Our analysis of 50 Genomics companies
$7.8b in tracked funding; 84% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Genomics companies in Sweden
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Immunovia Developer of protein diagnostics devices for the early detection of cancer | $57M | 72 mo ago | Public | 45 | Jeff Borcherding Chief Executive Officer | WordPressApple iCloud MailMicrosoft 365+30 | 173 patents Molecular diagnostic arrays for disease biomarkers, especially cancer and autoimmune conditions | 1 job opening · 1 launch |
| 2 | InDex Pharmaceuticals DNA-based immunomodulatory sequence medication for the treatment of inflammtatory bowel disease. | $45M | 81 mo ago | Public | 7 | — | — | 252 patents Nucleic‑acid‑based gastrointestinal therapeutics, especially ulcerative colitis enema formulations. | — |
| 3 | Elypta Provider of liquid biopsy-based molecular diagnostics for cancer detection | $28M | 48 mo ago | Series A | 27 | Karl Bergman CEO | WebflowAmazon Web ServicesPlausible+10 | 25 patents Diagnostic biomarker assays for cancer and arthritis using glycosaminoglycan profiling | 1 partnership |
| 4 | SweTree Developer of forest biotechnology for increased value of trees and wood | $19M | 216 mo ago | Series B | 21 | — | — | 331 patents Genetically engineered drought‑tolerant, high‑yield crops and advanced propagation technologies. | — |
| 5 | BioLamina Cell culture reagents for stem cell research | $18M | 2 mo ago | Series B | 75 | Magnus Kenneby Co-Founder | WordPress Block EditorCart FunctionalityWordPress+28 | 134 patents Stem cell differentiation protocols for retinal pigment epithelium and dopaminergic neurons | — |
| 6 | Devyser Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders | $15M | 64 mo ago | Public | 106 | — | DrupalApple iCloud MailMicrosoft 365+27 | — | — |
| 7 | Cavidi Provider of molecular diagnostic kits for diagnosis and monitoring of viral infections | $12M | 100 mo ago | Series B | 45 | — | Cart FunctionalityWooCommerceWordPress+37 | 14 patents Sensitive viral nucleic acid detection and antiviral susceptibility assay technologies. | 2 launchs |
| 8 | Senzagen Developer of genome-based immunotoxicology assays | $8M | 87 mo ago | Funding Raised | 33 | Anki Malmborg Hager CEO | WordPressMySQLPHP+20 | 88 patents In vitro cellular assay platforms and analytical arrays for respiratory sensitization testing | — |
| 9 | Single Technologies Developer of a technology platform for single-molecule imaging | $8M | 27 mo ago | Series A | 24 | — | — | — | — |
| 10 | Rarity Bioscience Developer of assays for diagnostics of cancer | $8M | 24 mo ago | Series A | 9 | Per Matsson Co-chair & co-founder | WordPressMySQLPHP+12 | 14 patents Targeted nucleic acid detection assays using variant-specific probes and blocking agents | 2 awards |
| 11 | iCellate Cancer profiling tool for precision oncology through liquid biopsy test | $4M | 36 mo ago | Series A | 19 | Pelle Redare Entrepreneur & Co-founder | — | — | — |
| 12 | CombiGene Provider of gene therapy for the treatment of rare diseases | $4M | 56 mo ago | Series B | 10 | — | — | 20 patents Gene therapy vectors targeting lipodystrophy and metabolic disease treatments | — |
| 13 | TATAA Biocenter CRO for molecular analysis offering scientific research, clinical trials and drug development | $3M | 30 mo ago | Funding Raised | 66 | — | WordPressApple iCloud MailMicrosoft 365+28 | 12 patents Small RNA library preparation and mutant nucleic acid detection assay technologies | 1 job opening |
| 14 | Epigenica Provider of solutions for the analysis of genomic data | $2M | 11 mo ago | Seed | — | Simon Alsatian Co-Founder | — | 14 patents High‑throughput multiplexed epigenomic profiling of cell‑free DNA and chromatin modifications | — |
| 15 | Metabogen Metagenomic services for the pharmaceutical industry. | $1M | 104 mo ago | Seed | 6 | — | — | 79 patents Microbiome‑based probiotic therapies for diabetes, bowel and liver disease treatment | — |
| 16 | TIGERQ Developer of gene editing and NGS analysis solutions | $1M | 63 mo ago | Seed | 2 | David Yudovich Co-Founder & CEO | — | 13 patents Computational analysis of nucleotide variant frequency distributions in genomic sequencing data. | — |
| 17 | Aligned Bio Provider of nanowire-based sensors | $909K | 21 mo ago | Seed | 17 | Jaime Castillo-Leon Co-Founder & Director | HubSpot CMS HubMicrosoft ClarityHubSpot+11 | — | — |
| 18 | Qlucore Provider of bioinformatics software for data visualization and exploration | $840K | 41 mo ago | Early Stage | 21 | — | — | 10 patents Statistical software for robust multivariate data analysis and comparison | 4 launchs |
| 19 | Merozyne Therapeutics Developer of drug to treat muscular dystrophy (MDC1A) | $690K | 115 mo ago | Deadpooled | — | Madeleine Durbeej-Hjalt Co-Founder & CSO | — | — | — |
| 20 | BiBB Provider of biopsy instrument for the detection of cancerous tumors | $530K | 93 mo ago | Seed | 3 | Fredrik Lindblad CEO | WordPressMySQLPHP+7 | — | — |
| 21 | CARTANA Provider of gene expression mapping technology in brain tissue | $330K | 77 mo ago | Acquired | 18 | Xiaoyan Qian Co-Founder | — | 11 patents Molecular diagnostics for nucleic acid detection, sequencing, and RNA‑templated ligation. | — |
| 22 | Cereduce Metabolic engineering of yeast for low alcohol fermentation | $204K | 169 mo ago | Deadpooled | 2 | Fredrik Weschke CEO | — | 5 patents Engineered yeast with chimeric glucose transporters for enhanced sugar uptake in bioprocessing | — |
| 23 | Carbiotix Developer of prebiotic ingredients and consumer products | $109K | 108 mo ago | Funding Raised | 9 | — | Chart.jsYouTubeBootstrap+9 | 16 patents Functional dietary fiber ingredients and diagnostics for gut microbiome health. | — |
| 24 | 1928 Diagnostics Provider of diagnostic software-as-a-service for antibiotic-resistant bacterial infections | $106K | 126 mo ago | Funding Raised | 17 | Kristina Lagerstedt Co-Founder & CEO | Cart FunctionalitySquarespace CommerceSquarespace+10 | — | — |
Top 12 Genomics companies in Sweden
#1
Series B · Sundbyberg, Stockholm County · founded 2008 · 75 employees$18.2Mraised▾
BioLamina is a biotechnology company that manufactures full-length human recombinant laminins for primary and stem-cell culture applications. The company's product portfolio includes recombinant laminins as cell culture matrices for specific uses like pluripotent stem cell culture, early epithelial development and differentiation, and kits with multiple laminins for screening the most appropriate matrix for specific cell types.
- Apr 2026Conventional Debt$23.6M
- Sep 2023Series B$18.2M
- Apr 2021Grant (prize money)$444.3K
- Aug 2009Grant (prize money)$331.6K
#2
Seed · Stockholm, Stockholm County · founded 2020$2.3Mraised▾
Provider of solutions for the analysis of genomic data. The platform is offering tools, EpiQure, for testing epigenetic drug efficacy and toxicity screening in real-life pilots, EpiFinder, for large-scale biomarker discovery for disease diagnosis and prognosis, and EpIVD, which helps in lowering the cost of epigenetic diagnostics.
- Jun 2025Seed$2.2M
- Jul 2022Grant (prize money)$125K
#3
Series A · Uppsala, Uppsala County · founded 2021 · 9 employees$7.5Mraised▾
Developer of assays for diagnostics of cancer. It offers molecular amplification technology to detect DNA sequence variants that are used to track cancer mutations in patients' tissue or liquid biopsies.
- Jun 2024Series A$7M
- Feb 2023Seed$539.6K
- Nov 2022Seed—
#4
Series A · Stockholm, Stockholm County · founded 2012 · 24 employees$7.6Mraised▾
Single Technologies has developed a platform for single-molecule imaging. The company's product includes the Model Theta, a single molecule sensitive confocal microscope that provides 3D video solution based on the photon-counting detector used for single-molecule imaging.
#5
Series A · Stockholm, Stockholm County · founded 2017 · 27 employees$27.9Mraised▾
Provider of liquid biopsy-based molecular diagnostics for cancer detection. The company offers a liquid biopsy platform for the detection and monitoring of the disease. The test is based on the measurement of various biomarkers. The test uses machine learning algorithms to generate a score against cancer-type specific signatures. The test is primarily meant for renal cell carcinoma. The test helps in early detection, differential diagnosis, and monitoring or prediction of treatment response, replacing or complementing medical imaging.
- Jun 2022Series A$21M
- May 2022Grant (prize money)$53.8K
- Dec 2019Seed$6.9M
- May 2019Grant (prize money)$2.6M
#6
Seed · Lund, Skane County · founded 2019 · 17 employees$908.5Kraised▾
Provider of nanowire-based sensors. It provides nanowire material types and dimensions to organize and align the nanowires on platforms. It also provides technology to enable nanowires to detect single molecules at an order of magnitude optical contrast. It also owns a patent regarding nanowire development.
- Aug 2024Seed$389.7K
- 2023Grant (prize money)$54.6K
- Jun 2022Grant (prize money)$2.5M
- Oct 2019Seed$518.8K
#7
Public · Lund, Skane County · founded 2007 · 45 employees$56.8Mraised▾
Developer of protein diagnostics devices for the early detection of cancer. The company uses a library of human recombinant scFv antibody probes to identify clinically relevant biomarkers for cancer. It also has a proteomics survey platform called IMMra PS for global proteomic analysis. Its flagship product IMMray PanCan-D is a microarray chip that can detect pancreatic cancer with a single drop of blood.
- Jun 2020Post IPO$42.8M
- May 2018Grant (prize money)$4.9M
- Jun 2015Grant (prize money)$4.6M
- Mar 2015Grant (prize money)$4.5M
#8
Public · Stockholm, Stockholm County · founded 2000 · 7 employees$45.4Mraised▾
InDex Pharmaceuticals develops drugs for the treatment of ulcerative colitis. It offers Kappaproct, a DNA-based immunomodulatory sequence medication (TLR Agonists) that provides a local anti-inflammatory effect leading to healing of the mucosa and improvement of clinical symptoms for patients with severe ulcerative colitis; and DiBiCol, a diagnostic test that differentiates between ulcerative colitis and Crohn’s disease, the two major forms of inflammatory bowel disease.
- Sep 2019PE$14.1M
- Aug 2018Grant (prize money)$58.4K
- Mar 2017Grant (prize money)$200.6K
- Sep 2016Post IPO$14.4M
#9
Funding Raised · Gothenburg, Vastra Gotaland County · founded 2001 · 66 employees$2.9Mraised▾
CRO for molecular analysis offering scientific research, clinical trials and drug development. It offers a wide range of bioanalytical services to help support drug development in the pharmaceutical industry. Its services include PCR services, NGS, and protemics.
- Dec 2023Grant (prize money)$27.4K
- Jan 2021Grant (prize money)$601.4K
- Apr 2020Grant (prize money)$288.6K
- Jan 2020Grant (prize money)$1.2M
#10
Series A · Solna, Stockholm County · founded 2011 · 19 employees$4.2Mraised▾
Cancer profiling tool for precision oncology through liquid biopsy test. It offer CellMate a next generation circulating tumor test for the detection of cancer by analysing of blood and saliva samples to healthcare providers and individual consumers.
- Jun 2023Series A$1.8M
- Jul 2021Grant (prize money)$1.2M
- Dec 2019Series A$2.4M
#11
Public · Stockholm, Stockholm County · founded 2004 · 106 employees$15.5Mraised▾
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders. The company's products include NGS-based kits for the characterization of BRCA 1/2, NGS-based gene panel tests for familial hypercholesterolemia, cystic fibrosis, thrombophilia, hereditary hemochromatosis, APOE characterization for risk of late-onset Alzheimer’s disease, cardiovascular disease, QF-PCR-based tests for prenatal aneuploidy, and a range of cytogenetic defects.
- Feb 2021Series B$15.5M
- Jan 2021Grant (prize money)$905.4K
#12
Series B · Umea, Vasterbotten County · founded 1999 · 21 employees$19.3Mraised▾
Developer of forest biotechnology for increased value of trees and wood. The company develops technologies and products for the forestry market. It collaborates with customers and scientists to create biotechnology solutions. The aim is to sustainably produce biomass and enable exchange from fossils into renewables. The company focuses on efficient resource use to increase the BioEconomy.
- 2008Series B$10.7M
- 2005Series A$6.3M
- 2002Unattributed$1.6M
- 2001Unattributed$639.3K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Genomics coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics is moving in Sweden
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 715 Sweden-affiliated papers.
- Karolinska Institutet214
- Science for Life Laboratory88
- Lund University87
- Karolinska University Hospital86
- Uppsala University62
- Transcriptome3→23
- Proteomics2→19
- Gene2→17
- Genome2→15
- Population1→10
- Disease1→33
- Proteomics1→10
- Population1→8
- In silico1→6
- Proteome1→6
- Microbiome1→7
- Immune system1→6
- Transcriptome1→5
- Mechanism (biology)1→5
- Gene1→5
Where bioinformatics is researched across Sweden
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.